Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00775996 · ClinicalTrials.gov registry record · NA

Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions

A NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT00775996: Completed NA study of Healthy, sponsored by Ranbaxy Laboratories Limited.

NCT00775996 is a NA study of Healthy that has completed, run by Ranbaxy Laboratories Limited. The registered enrollment target is 32 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00775996, a NA study of Healthy, has completed, sponsored by Ranbaxy Laboratories Limited.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions.

Conditions Studied

Healthy

Interventions

  • DRUG Clorazepate Dipotassium 15mg Tablets

Study Locations (1)

Nebraska

  • MDS Pharma Services - Lincoln

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2003-08
Est. Completion 2003-11
Phase NA

Sponsor

Ranbaxy Laboratories Limited

44 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00775996

The ClinicalTrials.gov registry entry for NCT00775996 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is Ranbaxy Laboratories Limited, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Clorazepate Dipotassium 15mg Tablets is the first listed.

NCT00775996 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT00775996 about?

NCT00775996 is a clinical study titled "Bioequivalence Study of Clorazepate Dipotassium 15mg Tablets Under Fasting Conditions". The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions.

What is the current status of trial NCT00775996?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2003-08. Estimated completion is 2003-11.

What conditions does trial NCT00775996 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00775996?

The interventions under investigation include: Clorazepate Dipotassium 15mg Tablets (DRUG).

Who is sponsoring clinical trial NCT00775996?

This trial is sponsored by Ranbaxy Laboratories Limited, which has 44 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00775996 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.